3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
36
Leukemia
18
Lymphoma, Non-Hodgkin
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Congenital Abnormalities
8
Lymphoma
7
Multiple Myeloma
6
Lymphoma, Follicular
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Hematologic Neoplasms
6
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell
5
Lymphoma, B-Cell, Marginal Zone
4
Recurrence
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myeloid
3
Hodgkin Disease
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Lymphoma, Large-Cell, Immunoblastic
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Colorectal Neoplasms
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
Interventions
Psychiatric Rehabilitation
2
Counseling
2
Bupropion
2
pembrolizumab
1
ixabepilone
1
fludarabine
1
Zinc Oxide
1
Varenicline
1
Tobacco Use Cessation Devices
1
Tissue Banks
1
Quality of Life
1
Psychology, Positive
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Observation
1
Nicotine Replacement Therapy
1
Nicotine
1
Molecular Diagnostic Techniques
1
Methods
1
Leucovorin
1
Interleukin-2
1
Interleukin-15
1
Immunotherapy
1
Gene Expression Profiling
1
Gemcitabine
1
Fluorouracil
1
Early Intervention, Educational
1
Drug Therapy
1
Cyclophosphamide
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Interleukin-2
×
Other hematologic neoplasm
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled